Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-18

Clinical Trial Update: A Pilot Study Investigating the Efficacy of Minocycline and N-Acetyl Cysteine for Bipolar Depression [Phase 4]

View source ↗

Summary

A Phase 4 pilot study evaluating the efficacy of minocycline and N-acetylcysteine for bipolar depression has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minocycline (minocycline)
  • N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Bipolar Disorder, Bipolar Depression | Phase 4 | Status: SUSPENDED